Authors:
Moalic, V
Moalic, E
Bellein, V
Jezequel, J
Garre, M
Berthou, C
Le Flohic, AM
Citation: V. Moalic et al., First identification of Candida dubliniensis in the Brest University Hospital (France), J MYCOL MED, 11(1), 2001, pp. 32-37
Authors:
Garre, M
Potard, M
Hiar, I
Tonnelier, JM
Gentric, A
Citation: M. Garre et al., Antimicrobial therapy of community-acquired pneumonia. New antibiotics, abreviated course treatment, cost-benefit analysis., MED MAL INF, 31(4), 2001, pp. 174-180
Authors:
Raffi, F
Reliquet, V
Ferre, V
Arvieux, C
Hascoet, C
Bellein, V
Besnier, JM
Breuz, JP
Garre, M
May, T
Molina, JM
Perre, P
Raguin, G
Rozenbaum, W
Zucman, D
Citation: F. Raffi et al., The VIRGO Study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults, ANTIVIR TH, 5(4), 2000, pp. 267-272
Authors:
Bibes, B
Camus, C
Le Corre, C
Garre, M
Cartier, F
Citation: B. Bibes et al., Streptococcal meningitis following a lumbar puncture: case reports and literature review, MED MAL INF, 30(3), 2000, pp. 169-172
Authors:
Nicolas, X
Gentric, AT
Cholet, F
Hiar, I
Pennec, YL
Garre, M
Citation: X. Nicolas et al., Capillary leak syndrome and Gaucher's disease: responsability of the monoclonal gammapathy?, REV MED IN, 21(12), 2000, pp. 1128-1129
Authors:
Raffi, F
Reliquet, V
Francois, C
Garre, M
Hascoet, C
Allavena, C
Arvieux, C
Breux, JP
Perre, P
Rozenbaum, W
Auger, S
Citation: F. Raffi et al., Stavudine plus didanosine and nevirapine in antiretroviral-naive HIV-infected adults: preliminary safety and efficacy results, ANTIVIR TH, 3, 1998, pp. 57-60